20 January 2022 | News
Mudaliar will be responsible for establishing and expanding the CDI footprint in India
AstraZeneca India announced the appointment of Ram Mudaliar as the India lead of their Clinical Data & Insights (CDI) division. Mudaliar worked with AstraZeneca Canada, managing the delivery of the lung portfolio and leading oncology data management teams in the North American region and Europe. He has also worked as Interim Global Head of Oncology in Data Management for a brief period.
Mudaliar’s appointment follows the launch of the CDI India division in October 2021.
As CDI India Lead, Mudaliar will be responsible for establishing and expanding the CDI footprint in India, liaising with CDI global and local leaders to develop and implement strategic decisions for the India site. He is also responsible for ensuring the local planning and coordination relating to facilities and enabling support for the India team, connecting with Facilities Management, Human Resources, IT, Compliance, R&D Site Leadership and other functions as required.
Mudaliar holds a master’s degree in Biotechnology from Mumbai University in India. Ram’s passion has always been about data and insights and is particularly fascinated by the possibilities it brings in enabling patient-centric solutions. Before joining AstraZeneca, Mudaliar has worked with Cognizant Technology Solutions where he was responsible for Clinical Data Management, Statistical Programming, Analysis and Medical Writing. Ram has been with AstraZeneca for over five years and has served various roles across countries and continents under the clinical data management domain.